Condom Effectiveness for Reducing Transmission of Gonorrhea and Chlamydia: The Importance of Assessing Partner Infection Status

American Journal of Epidemiology

Volumn 159, Issue 3, 2004, Pages 242-251

  Warner, Lee ^a,b,c   Newman, Daniel R ^a   Austin, Harland D ^b   Kamb, Mary L ^c   Douglas Jr , John M ^d   Malotte, C Kevin ^e   Zenilman, Jonathan M ^f,g   Rogers, Judy ^h   Bolan, Gail ⁱ   Fishbein, Martin ^j   Kleinbaum, David G ^b   Macaluso, Maurizio ^k   Peterman, Thomas A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d California State Univ Long Beach ^*  (United States)

^e CALIFORNIA STATE UNIVERSITY   (United States)

^f BALTIMORE CITY HEALTH DEPARTMENT   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Newark Department of Public Health   (United States)

ⁱ San Francisco Department of Health   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

more..

Author keywords

Chlamydia; Contraceptive devices, male; Gonorrhea; HIV infections; Sexual behavior; Sexually transmitted diseases

Indexed keywords

LATEX;

SEXUALLY TRANSMITTED DISEASE;

ADULT; ARTICLE; CHLAMYDIASIS; CONDOM; CONTROLLED STUDY; DATA ANALYSIS; DOSE TIME EFFECT RELATION; EPIDEMIOLOGICAL DATA; FEMALE; GONORRHEA; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PREVALENCE; RESTRICTION MAPPING; RISK ASSESSMENT; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; CHLAMYDIA INFECTIONS; CONDOMS; EDUCATIONAL STATUS; FEMALE; GONORRHEA; HUMANS; LOGISTIC MODELS; MALE; SEXUAL BEHAVIOR; UNITED STATES;

EID: 9144248946     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh044     Document Type: Article

References (60)

1. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-6):1-78.
2. Condoms for prevention of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1988;37:133-7.
3. Mann JR, Stine CC, Vessey J. The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom. Sex Transm Dis 2002;29:344-9.
4. Medical Institute of Sexual Health. Sex, condoms & STDs: what we now know. Austin, TX: Medical Institute of Sexual Health, 2002.
5. Stone KM, Thomas E, Timyan J. Barrier methods for the prevention of sexually transmitted diseases. In: Holmes KK, Sparling PF, Mardh PA, et al, eds. Sexually transmitted diseases. 3rd ed. New York, NY: McGraw-Hill, 1998:1307-21.
6. Judson FN, Ehret JM, Bodin GF, et al. In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis 1989;16:51-6.
7. Minuk GY, Bohme CE, Bowen TJ, et al. Efficacy of commercial condoms in the prevention of hepatitis B virus infection. Gastroenterology 1987;93:710-14.
8. Carey RF, Lytle CD, Cyr WH. Implications of laboratory tests for condom integrity. Sex Transm Dis 1999;26:216-20.
9. Carey RF, Herman WA, Retta SM, et al. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sex Transm Dis 1992;19:230-4.
10. Rietmeijer CAM, Krebs JW, Feorina PM, et al. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA 1988;259:1851-3.
11. Lytle CD, Routson LB, Seaborn GB, et al. An in vitro evaluation of condoms as barriers to a small virus. Sex Transm Dis 1997;24:161-4.
12. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999;31:272-9.
13. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997;44:1303-12.
14. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-6.
15. Austin H, Louv WC, Alexander J. A case-control study of spermicides and gonorrhea. JAMA 1984;251:2822-4.
16. Barlow D. The condom and gonorrhoea. Lancet 1977;222:811-12.
17. Darrow WW. Condom use and use-effectiveness in high-risk populations. Sex Transm Dis 1989;16:157-60.
18. Fennema JS, van Ameijden EJ, Coutinho RA, et al. Clinical sexually transmitted diseases among human immunodeficiency virus-infected and noninfected drug-using prostitutes. Associated factors and interpretation of trends, 1986 to 1994. Sex Transm Dis 1997;24:363-71.
19. Gaydos CA, Howell RM, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739-44.
20. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978;108:136-44.
21. Joesoef MR, Linnan M, Barakbah Y, et al. Patterns of sexually transmitted diseases in female sex workers in Surabaya, Indonesia. Int J STD AIDS 1997;8:576-80.
22. Levine WC, Revollo R, Kaune V, et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS 1998;12:1899-906.
23. Pemberton J, McCann JS, Mahony JD, et al. Socio-medical characteristics of patients attending a V.D. clinic and the circumstances of infection. Br J Vener Dis 1972;48:391-6.
24. Peters SE, Beck-Sague CM, Farshy CE, et al. Behaviors associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin Pediatr 2000;39:173-7.
25. Ramstedt K, Forssman L, Giesecke J, et al. Risk factors for Chlamydia trachomatis in 6810 young women attending family planning clinics. Int J STD AIDS 1992;3:117-22.
26. Rosenberg MJ, Davidson AJ, Chen JH, et al. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health 1992;82:669-74.
27. Sanchez J, Gotuzzo E, Escamilla J, et al. Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination program. Sex Transm Dis 1998;25:82-9.
28. Schwartz MA, Lafferty WE, Hughes JP, et al. Risk factors for urethritis in heterosexual men. Sex Transm Dis 1997;24:449-55.
29. Upchurch DM, Brady WE, Reichart CA, et al. Behavioral contributions to acquisition of gonorrhea in patients attending an inner-city sexually transmitted disease clinic. J Infect Dis 1990;161:938-41.
30. Zelin JM, Robinson AJ, Ridgway GL, et al. Chlamydial urethritis in heterosexual men attending a genitourinary medicine clinic: prevalence, symptoms, condom usage and partner change. Int J STD AIDS 1995;6:27-30.
31. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis 1995;22:15-21.
32. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. July 20, 2001. (http://www.niaid.nih.gov/dmid/stds/condomreport.pdf).
33. Aral S, Peterman TA. A stratified approach to untangling the behavioral/biomedical outcomes conundrum. Sex Transm Dis 2002;29:530-2.
34. Cates W Jr. The NIH condom report: the glass is 90% full. Fam Plann Perspect 2001;33:231-3.
35. Crosby R, DiClemente RJ, Holtgrave DR, et al. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002;78:228-31.
36. Fishbein M, Pequegnat W. Evaluating AIDS prevention interventions using behavioral and biological outcome measures. Sex Transm Dis 2000;37:101-10.
37. Peterman TA. Can we measure STD risk behavior or STD as surrogates for HIV risk? Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2002;45:286-90.
38. Peterman TA, Lin LS, Newman DR, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Sex Transm Dis 2000;27:446-51.
39. Turner CF, Miller HG. Zenilman's anomaly reconsidered: fallible reports, ceteris paribus, and other hypotheses. Sex Transm Dis 1997;24:522-7.
40. Steiner MJ, Feldblum PJ, Padian N. Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol 2003;157:298-300.
41. Warner L, Clay-Warner J, Boles J, et al. Assessing condom use practices: implications for evaluating method and user effectiveness. Sex Transm Dis 1998;25:273-7.
42. Wamer DL, Steiner MJ, Hatcher RA. Male condoms. In: Hatcher RA, Guest F, Stewart F, et al, eds. Contraceptive technology. 18th ed. New York, NY: Ardent Media (in press).
43. Macaluso M, Artz L, Kelaghan J, et al. Prospective study of barrier contraception for the prevention of sexually transmitted diseases. Sex Transm Dis 1999;26:127-36.
44. Warner L, Newman D, Peterman T, et al. Studying condom effectiveness for sexually transmitted disease (STD) prevention: the importance of knowing partner infection status. Presented at the National STD Prevention Conference, San Diego, California, March 4-7, 2002.
45. Macaluso M, Demand MJ, Artz LM, et al. Partner type and condom use. AIDS 2000;14:537-46.
46. Shain RN, Perdue ST, Piper JM, et al. Behaviors changed by intervention are associated with reduced STD recurrence: the importance of context in measurement. Sex Transm Dis 2002;29:520-9.
47. Thomas JC, Stratton S. Sexual transmission. In: Thomas JC, Weber DJ, eds. Epidemiologic methods for the study of infectious diseases. New York, NY: Oxford University Press, 2001:267-87.
48. Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexual transmitted diseases. JAMA 1998;280:1161-7.
49. Pinkerton SD, Chesson HW, Layde PM, et al. Utility of behavioral changes as markers of sexually transmitted disease risk reduction in sexually transmitted disease/HIV prevention trials. J Acquir Immune Defic Syndr 2002;31:71-9.
50. Aral SO, Peterman TA. Measuring outcomes of behavioural interventions for STD/HIV prevention. Int J STD AIDS 1996;7(suppl 2):30-8.
51. Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 2nd ed. New York, NY: Springer-Verlag New York, Inc, 2002.
52. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York, NY: Van Nostrand Reinhold Company Inc, 1982.
53. Rothman KJ, Greenland S, eds. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1998.
54. Halloran ME, Longini IM Jr. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol 2001;154:391-8.
55. Giesecke J. Modern infectious disease epidemiology. New York, NY: Oxford University Press, 1994.
56. Cates W Jr, Holmes KK. Re: "Condom efficacy against gonorrhea and nongonococcal urethritis." (Letter). Am J Epidemiol 1996;143:843-4.
57. Lycke E, Lowhagen GB, Hallhagen G, et al. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis 1980;7:6-10.
58. Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983;250:3205-9.
59. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996;276:1737-42.
60. Schachter J, Chow JM. The fallibility of diagnostic tests for sexually transmitted diseases: the impact of behavioral and epidemiologic studies. Sex Transm Dis 1995;22:191-6.